A Randomized Placebo-Controlled Trial of Risperidone for the Treatment of Aggression, Agitation, and Psychosis of Dementia - Concepedia

Concepedia

Publication | Closed Access

A Randomized Placebo-Controlled Trial of Risperidone for the Treatment of Aggression, Agitation, and Psychosis of Dementia

466

Citations

0

References

2003

Year

Henry Brodaty, David Ames, John Snowdon, Michael Woodward, Jeff Kirwan, Roger Clarnette, Emma Lee, Ben Lyons, Fred Grossman

The Journal of Clinical Psychiatry

Abstract

Treatment with low-dose (mean = 0.95 mg/day) risperidone resulted in significant improvement in aggression, agitation, and psychosis associated with dementia.